Skip to main content
Clinical Trials/NCT01421550
NCT01421550
Unknown
Phase 3

Conservative Treatment Versus Elective Repair of the Umbilical Hernia in Patients With Ascites and Liver Cirrhosis, a Randomized Controlled Trial

Erasmus Medical Center1 site in 1 country100 target enrollmentJanuary 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Umbilical Hernia
Sponsor
Erasmus Medical Center
Enrollment
100
Locations
1
Primary Endpoint
complications
Last Updated
14 years ago

Overview

Brief Summary

The purpose of the present study is to investigate whether or not to perform elective surgical repair of umbilical hernias in patients with liver cirrhosis and ascites. There are no other randomized controlled trials in this area. The optimal management in patients with umbilical hernias and liver cirrhosis with ascites is not clear yet. The general surgical opinion is that umbilical hernias in patients with ascites should not be corrected because of the supposedly high operative risks and high recurrence rates. Conservative treatment, however, can have severe complications resulting in emergency repair. Such operations carry a higher risk of complications than elective operations, particularly in this group of patients. Prospective and retrospective series showed us that elective hernia repair in this specific patient group is safe without major complications or high recurrence rates.

The aim of this study is to asses the optimal timing of correction of umbilical hernia in patients with liver cirrhosis and ascites.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
December 2015
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

hasan eker

Dr. G. Kazemier

Erasmus Medical Center

Eligibility Criteria

Inclusion Criteria

  • Primary Umbilical hernia
  • Liver cirrhosis
  • Ascites (US proven)
  • Age ≥ 18 years
  • Signed Informed consent

Exclusion Criteria

  • Recurrent umbilical hernia
  • Midline laparotomy in medical history
  • ASA1 score IV or above
  • Incarcerated hernia related emergency procedures
  • Patent umbilical vein; \>5mm
  • Expected time to Ltx \<3 months

Outcomes

Primary Outcomes

complications

Time Frame: 2 years

The primary endpoint in this study is a composite endpoint of the overall morbidity after 24 months, which includes; Reoperation for complication (e.g. hemorrhage; Decompensated liver failure(e.g. Portal vein thrombosis; Non-closure of surgical wound at 4 weeks; Haematoma; Seroma; Rupture of hernia; Bowel incarceration; Necrosis and rupture of the overlying skin; Evisceration; Pneumonia; Urinal tract infection; Postoperative surgical site infection (superficial/deep/organ space); Postoperative leakage of ascites more than 2 weeks after surgery

Secondary Outcomes

  • Recurrence(2 years)
  • Mortality(2 years)
  • Length of hospital stay(3 months)
  • Quality of life(2 years)
  • Cost effectiveness(2 years)

Study Sites (1)

Loading locations...

Similar Trials